JILL HINDES: Open Payments
NPI 1578841466 · SOUTH SETAUKET, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,443 in 131 payments from 11 companies in 2025. Trend: 2023 $2,986 · 2024 $2,506 · 2025 $2,443
Food & beverage: $2,443
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 44 | $656 |
| Neurocrine BioSciences, Inc. | 14 | $312 |
| Supernus Pharmaceuticals, Inc. | 11 | $249 |
| ABBVIE INC. | 12 | $249 |
| Axsome Therapeutics, Inc. | 12 | $226 |
| Lundbeck LLC | 13 | $226 |
| Otsuka America Pharmaceutical, Inc. | 10 | $215 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $201 |
| Corium, LLC | 4 | $74 |
| Almatica Pharma LLC | 1 | $18 |
Products named: CAPLYTA, REXULTI, INGREZZA, Qelbree, VRAYLAR, Auvelity, TRINTELLIX, Azstarys.
Industry payments across NY — which companies pay providers there.
